-
J286608-10mgPotent and selective MAGL inhibitor
-
K287859-100mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.
-
K287859-10mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.
-
K287859-25mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.
-
K287859-50mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.
-
K287859-5mgProduct Describtion:KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.
-
L287140-10mgInositol monophosphatase inhibitor
-
L287140-50mgInositol monophosphatase inhibitor
-
M288047-100mgSelective ATP competitive SphK1 and 2 inhibitor cell permeable
-
M288047-10mgSelective ATP competitive SphK1 and 2 inhibitor cell permeable
-
M288047-25mgSelective ATP competitive SphK1 and 2 inhibitor cell permeable
-
M288047-50mgSelective ATP competitive SphK1 and 2 inhibitor cell permeable